Literature DB >> 24205446

Influence of Stromal Components on Lung Cancer Carcinogenesis.

Laurie A Shuman Moss1, William G Stetler-Stevenson.   

Abstract

The association between tumor growth and angiogenesis was first observed over 100 years ago. Since then, research has shown the dependence of tumor growth on angiogenesis and the ability of cancer cells to alter the stromal microenvironment. Technological advancements have enabled researchers to identify cell types within a tumor, identify chemokines, cytokines, and growth factors secreted by tumor cells, show the interaction between tumor cells and stroma, and investigate the function of distinct genes using knockout and transgenic mouse technology. This review provides an overview of tumor growth, emphasizing research using in vivo mouse models on vascular endothelial growth factor (VEGF), fibrinogen, fibronectin, plasminogen, and MMPs in primary tumor growth and metastasis of lung cancer in particular.

Entities:  

Keywords:  Fibrinogen; Fibronectin; Lung cancer; Matrix metalloproteinases; Plasminogen; TIMPs; VEGF

Year:  2013        PMID: 24205446      PMCID: PMC3818080          DOI: 10.4172/2157-2518.S13-008

Source DB:  PubMed          Journal:  J Carcinog Mutagen


  50 in total

1.  The anti-angiogenic peptide, loop 6, binds insulin-like growth factor-1 receptor.

Authors:  Cecilia A Fernandez; Roopali Roy; Sunyoung Lee; Jiang Yang; Dipak Panigrahy; Krystyn J Van Vliet; Marsha A Moses
Journal:  J Biol Chem       Date:  2010-10-12       Impact factor: 5.157

2.  Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion.

Authors:  Gunjan Malik; Lynn M Knowles; Rajiv Dhir; Shuping Xu; Shuting Yang; Erkki Ruoslahti; Jan Pilch
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

3.  Expression of extracellular matrix molecules in brain metastasis.

Authors:  Seiichi Yoshida; Hideaki Takahashi
Journal:  J Surg Oncol       Date:  2009-07-01       Impact factor: 3.454

Review 4.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

5.  Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice.

Authors:  T H Bugge; K W Kombrinck; Q Xiao; K Holmbäck; C C Daugherty; D P Witte; J L Degen
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

6.  Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.

Authors:  Jasti S Rao; Christopher Gondi; Chandramu Chetty; Subramanyam Chittivelu; Pushpa A Joseph; Sajani S Lakka
Journal:  Mol Cancer Ther       Date:  2005-09       Impact factor: 6.261

Review 7.  The plasminogen activation system in tumor growth, invasion, and metastasis.

Authors:  P A Andreasen; R Egelund; H H Petersen
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

8.  Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies.

Authors:  Hans-Peter Gerber; Napoleone Ferrara
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

9.  Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.

Authors:  B Casar; Y He; M Iconomou; J D Hooper; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2011-12-19       Impact factor: 9.867

10.  Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.

Authors:  Z S Zeng; J G Guillem
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more
  4 in total

1.  Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.

Authors:  Asaf Madi; Sharron Bransburg-Zabary; Ayala Maayan-Metzger; Gittit Dar; Eshel Ben-Jacob; Irun R Cohen
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

Review 2.  Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy.

Authors:  Annele Sainio; Hannu Järveläinen
Journal:  Mol Cell Ther       Date:  2014-05-02

3.  The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells.

Authors:  Christina Cho; Carol Horzempa; David Jones; Paula J McKeown-Longo
Journal:  BMC Cancer       Date:  2016-08-02       Impact factor: 4.430

4.  STIM1 silencing inhibits the migration and invasion of A549 cells.

Authors:  Yadong Wang; Haiyu Wang; Teng Pan; Li Li; Jiangmin Li; Haiyan Yang
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.